STAT+: Federal judge blocks noncompete ban, and FTC considers appeal
A federal judge in Texas appointed by former President Donald Trump has officially spiked the…
Category: FTC
STAT+: Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants?
As the Federal Trade Commission scrutinizes the pharmaceutical industry, there is growing debate about whether…
STAT+: AI app claiming to diagnose STIs from penis pictures shut down after FTC scrutiny
The company that claimed its AI model could identify sexually transmitted infections from a single…
Opinion: Senate, FTC cracking down on pharma patent shenanigans
Why do Americans pay so much more for common medications than people in other countries?…
STAT+: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?
In a bid to prevent the patent system from being abused, the U.S. Patent and…
STAT+: FTC loses its bid to block Novant’s hospital merger in North Carolina
A federal judge ordered Wednesday that Novant Health can move forward with its plan to…
STAT+: Class action against UnitedHealth asks about DOJ probe transparency
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Private equity escapes FTC in court, but anesthesia group doesn’t
Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade…
STAT+: Biden administration boosts some Medicaid payments to match commercial rates
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: FTC’s noncompete ban immediately challenged in Texas district lawsuit
Vindication came swiftly on Wednesday for those who predicted legal challenges to the Federal Trade…
STAT+: Anticompetitive hospital mergers skate by due to FTC’s shallow resources
Over the past two decades, hundreds of hospital mergers have escaped federal antitrust scrutiny and…
STAT+: FTC’s noncompete ban would force sweeping changes in health care, if it survives legal battle
The Federal Trade Commission approved a far-reaching noncompete ban Tuesday that could force sweeping changes…
.jpg)
STAT+: The evidence grows: Prices spike after mergers between far-flung hospitals
The trend is clear: When hospitals in the same community merge, prices spike. The government…
STAT+: Cerebral to pay $7 million fine and limit health data use for ads under federal order
Telehealth company Cerebral will limit the consumer health data it uses for advertising purposes under…
STAT+: FTC cracks down on telehealth addiction service Monument for sharing health data
On Thursday, the Federal Trade Commission took action against alcohol addiction telehealth company Monument, affirming…
STAT+: Explaining Change Healthcare and the gravity of its cyberattack
The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it…
STAT+: FTC to probe the role of middlemen in worsening drug shortage crisis
The Federal Trade Commission is launching a probe into the extent to which group purchasing…
STAT+: FTC doubles down in Welsh Carson anesthesia case to limit private equity’s physician buyouts
Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Last…
STAT+: FTC sues to block a proposed hospital deal in North Carolina
The federal government is suing to block a proposed hospital deal in North Carolina, alleging…
STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’
Over the past two years, the U.S. Federal Trade Commission has attempted to crack down…
Opinion: The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs
In June, the Food and Drug Administration issued a warning letter about advertisements for the…
STAT+: HHS names inaugural chief competition officer
The Department of Health and Human Services will name Stacy Sanders as its new chief…
What the new health counsels at FTC, DOJ, and HHS might do
Three major government agencies are adding new officials to investigate price-gouging in health care —…
Listen: FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally…
STAT+: Hot antitrust environment hangs over called-off merger between Cigna and Humana
Less than two weeks after reports surfaced saying Cigna and Humana were considering combining into…
Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents
With 10 days to go, only one company has responded to a demand by the…
STAT+: U.S. Anesthesia Partners, Welsh Carson face class action over monopoly allegations
Union health plans that represent electricians and plumbers in Texas have filed a class action…
Kaiser Permanente workers announce an official strike date
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
FTC sues private equity firm Welsh Carson, U.S. Anesthesia Partners for allegedly creating a monopoly
The Federal Trade Commission has sued U.S. Anesthesia Partners and its private equity owner, Welsh,…
STAT+: Patients, doctors press FTC to beef up hospital merger scrutiny
Comments to antitrust regulators lay bare Americans’ anger and disillusionment over consolidation’s effects on all…
Opinion: Where are HHS and the FTC on online privacy for people with substance use disorder?
The era of rampant, unconsented, and unregulated online data collection may finally be winding down…
STAT+: FTC warns drugmakers they can face legal action over improper patent filings
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly…
STAT+: U.S. appeals court strike down key provisions in Oklahoma law that regulates PBMs
A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate…
STAT+: ‘No data more personal’: Patients, digital health players weigh in on the FTC’s data privacy plan
This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible…
STAT+: FTC plans to reverse years of policy statements supporting pharmacy benefit managers
The U.S. Federal Trade Commission is reversing years of prior advocacy in support of pharmacy…
STAT+: DOJ, FTC primed for more aggressive scrutiny of health care mergers
Health care companies trying to merge can expect tougher policing from the top federal antitrust…
STAT+: FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers
In an unexpected move, the U.S. Federal Trade Commission on Tuesday filed a lawsuit to…
STAT+: HCA, Louisiana hospital system sue FTC over review of hospital deal
HCA Healthcare and LCMC Health each sued the Federal Trade Commission and Department of Justice…
STAT+: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade…
STAT+: Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study finds
Hospitals that merge under state regulations that shield them from federal scrutiny tend to eventually…
STAT+: Pharmalittle: Sarepta halts a Duchenne clinical trial over safety; Why the CVS Health whistleblower lawsuit comes at a pivotal moment
And so, another working week will soon draw to a close. Not a moment too…
STAT+: New Jersey hospitals scrap merger after FTC challenge
Two New Jersey hospital systems have called off their proposed merger less than two weeks…
The Senate health committee finally marks up its user fee bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
WASHINGTON — Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether…
STAT+: The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it
After the Federal Trade Commission’s flashy announcements last week that it was suing to block…